Does treatment with antihypertensive agents improve five-year survival in patients with malignant hypertension?
Early treatment of malignant hypertension with antihypertensive agents significantly improves 5-year survival, demonstrating benefit across racial groups and in patients with advanced atherosclerosis.
In this article, Freis and Mohler, a medical student at Georgetown University, reported the findings of their five-year study on the survival rate among patients with malignant hypertension. They concluded that treatment with antihypertensive agents prior to renal failure greatly enhanced a patient's chances for survival, and even proved to provide a greater chance for patients who also had advanced atherosclerosis as a result of prolonged high blood pressure. Freis and Mohler also noted that African American patients who received treatment lived almost as long as white patients in the study.
Mohler et al. (Thu,) studied this question.